Omnicell, Inc. (OMCL) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts OMCL Hot Sheet
Price: $37.82 +1.86%
Financial Fact:
Cost of product revenues: 76.19M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenues: 76.19M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Omnicell, Inc. (NASDAQ: OMCL) reported Q2 EPS of $0.04, $0.02 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $75.4 million versus the consensus estimate of $73.98 million.
For earnings history and earnings-related data on Omnicell, Inc. (OMCL) click here.
For earnings history and earnings-related data on Omnicell, Inc. (OMCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Live Ventures (LIVE) Reports Q3 Loss of $0.34
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
